A smart pill is an ingestible capsule with miniaturized micro-electronics which includes an electric component such as sensors, cameras, microchip, etc. Wireless capsule, a receiver, and computer software are the basic components of smart pills procedure. Smart pills are used in a wide range of applications such as detection and monitoring of various physiological measures of the gastrointestinal tract, drug delivery, and patient monitoring. Smart pills are ingestible in nature and can be swallowed by the oral route of administration. Drug delivery by smart pills is emerging technology which shows significant opportunity for the pharmaceutical industry to exploit the untapped market in the coming years.

Request Sample Pages : https://tinyurl.com/ya2rr4ba

Increasing incidence of chronic diseases such as gastrointestinal tract disease, colorectal cancer, etc. and rising geriatric population are expected to boost the demand for smart pills during the forecast period. For instance, according to the American Cancer Society, around 95,520 new cases of colon cancer and around 39,910 cases of rectal cancer were diagnosed in 2017 across the United States. In addition, increase in technological advances pertaining to smart pills such as miniaturization of electronic components and an integrated circuit, availability of microprocessors, integration of advanced and innovative drugs, and others are also expected to fuel the growth of smart pill market during the forecast period. Furthermore, the high adoption of minimally invasive surgeries and the paradigm shift from conventional techniques towards smart pills for diagnosis and monitoring of gastrointestinal tract disease have also fuelled the growth of the market during the forecast period. However, the technological incompetence of capsule endoscopes, huge cost of smart pill and dearth of skilled healthcare professionals are some of the factors which hinder the growth of the market.

Various notable players operating in the market, include Boston Scientific Corporation, Capsovision Inc., Chongqing Jinshan Science & Technology Group Co. Ltd., Fujifilm Holdings Corporation, GE Healthcare, Acamp, Given Imaging Inc., Intromedic Co. Ltd., Karl Storz Gmbh & Co., Medimetrics, Olympus Corporation, Pentax Medical Company, Proteus Digital Health Inc. among others.

Companies are focussing on merger & acquisition, collaboration, partnership, research, and development activities whereas, major companies are adopting merger & acquisition strategy to expand their geographical presence. For instance, in 2016, Boston Scientific Corporation acquired EndoChoice Holdings Inc.

The global smart pill market has been segmented on the basis of application, target area, indication, end user and key geographies. Based on Application, the market comprises capsule endoscopy, drug delivery, and patient monitoring. The research report “global smart pill market” provides in-depth analysis of global smart pill market based on application, target area, indication, end user and major geographies for the forecast period from 2018 to 2025. The report also highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for the global Smart Pill Market. In addition, the report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Key questions answered in this research report:
1- At what pace is smart pill market growing? What will be the growth trend in the future?
2- What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3- What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the smart pill market?
4- What are the various application areas and how they are poised to grow?

Market Segmentation
By Application Type
• Capsule Endoscopy
• Drug Delivery
• Patient Monitoring
By Target Area
• Esophagus
• Stomach
• Small Intestine
• Large Intestine
• Others
By Indication
• Esophageal Diseases
• Small Bowel Diseases
• Colon Diseases
• Others
By End User
• Hospital
• Diagnostic laboratories
• Ambulatory Surgical Center
• Research Institutes
• Others
By Geography
• North America
As a part of the customization
o By Application Type
o By Target Area
o By Indication
o By End User
o US
o Canada
o Mexico
• Europe
As a part of the customization
o By Application Type
o By Target Area
o By Indication
o By End User
o UK
o Germany
o Spain
o Rest of Europe
• Asia-Pacific
As a part of the customization
o By Application Type
o By Target Area
o By Indication
o By End User
o China
o Australia
o India
o Rest of APAC
• ROW
As a part of the customization
o By Application Type
o By Target Area
o By Indication
o By End User
o Brazil
o South Africa
o GCC countries
o Rest of world (remaining countries of the LAMEA region)
Leading market players
• Boston Scientific Corporation
• Capsovision Inc.
• Chongqing Jinshan Science & Technology Group Co. Ltd.
• Fujifilm Holdings Corporation
• GE Healthcare
• Acamp
• Given Imaging Inc.
• Intromedic Co. Ltd.
• Karl Storz Gmbh & Co. Kg
• Medimetrics
• Olympus Corporation
• Pentax Medical Company
• Proteus Digital Health Inc.

*Other prominent players in the market which can be profiled as a part of customization:
• Bio-Images Drug Delivery (BDD) Limited
• Quotient Clinical Ltd.
• Innovative Devices LLC,
• Cerner
• Bio-Images Research

For Sample Pages & Detailed Report Description Click @ https://www.gmiresearch.com/report/global-smart-pill-market-capsule-endoscopy-drug-delivery-patient-monitoring-target-area-indication-geography-opportunities-forecast-share-trends.html

Table of Contents (TOC)

1. Executive Summary

2. Introduction
2.1. Study Objectives
2.2. Market Definition
2.2.1. Market Covered
2.2.2. Geographical Coverage
2.2.3. Study Years & Currency
2.3. Market Stakeholders
2.4. Key Questions this Study will Answer
2.5. GMI Research’s Approach & Methodology
3. Global Smart Pill Market – Overview
3.1. Introduction
3.2. Global Healthcare Outlook `
3.3. Market Segmentation
3.4. Technology Assessment
3.5. Value Chain Analysis
3.6. Drivers
3.7. Restraints
3.8. Trends
4. Global Smart Pill Market Revenue Forecast till 2025

5. Global Smart Pill Market by Application Type Revenue Forecast till 2025
5.1. Capsule Endoscopy
5.2. Drug Delivery
5.3. Patient Monitoring
6. Global Smart Pill Market by Target Area Revenue Forecast till 2025
6.1. Esophagus
6.2. Stomach
6.3. Small Intestine
6.4. Large Intestine
6.5. Others
7. Global Smart Pill Market by Indication Revenue Forecast till 2025
7.1. Esophageal Diseases
7.2. Small Bowel Diseases
7.3. Colon Diseases
7.4. Others
8. Global Smart Pill Market by End User Revenue Forecast till 2025
8.1. Hospital
8.2. Diagnostic laboratories
8.3. Ambulatory surgical Center
8.4. Research Institutes
8.5. Others
9. Global Smart Pill Market by Geography Revenue Forecast till 2025
9.1. North America Smart Pill Market Revenue Forecast till 2025
9.1.1. North America Smart Pill Market by Application Type (Option 1: 25% customization)
9.1.1.1. Capsule Endoscopy
9.1.1.2. Drug Delivery
9.1.1.3. Patient Monitoring
9.1.2. North America Smart Pill Market by Target Area
9.1.2.1. Esophagus
9.1.2.2. Stomach
9.1.2.3. Small Intestine
9.1.2.4. Large Intestine
9.1.2.5. Others
9.1.3. North America Smart Pill Market by Indication
9.1.3.1. Esophageal Diseases
9.1.3.2. Small Bowel Diseases
9.1.3.3. Colon Diseases
9.1.3.4. Others
9.1.4. North America Smart Pill Market by End User
9.1.4.1. Hospital
9.1.4.2. Diagnostic laboratories
9.1.4.3. Ambulatory surgical Center
9.1.4.4. Research Institutes
9.1.4.5. Others
9.2. Europe Smart Pill Market Revenue Forecast till 2025
9.2.1. Europe Smart Pill Market by Application Type (Option 2: 25% customization)
9.2.1.1. Capsule Endoscopy
9.2.1.2. Drug Delivery
9.2.1.3. Patient Monitoring
9.2.2. Europe Smart Pill Market by Target Area
9.2.2.1. Esophagus
9.2.2.2. Stomach
9.2.2.3. Small Intestine
9.2.2.4. Large Intestine
9.2.2.5. Others
9.2.3. Europe Smart Pill Market by Indication
9.2.3.1. Esophageal Diseases
9.2.3.2. Small Bowel Diseases
9.2.3.3. Colon Diseases
9.2.3.4. Others
9.2.4. Europe Smart Pill Market by End User
9.2.4.1. Hospital
9.2.4.2. Diagnostic laboratories
9.2.4.3. Ambulatory surgical Center
9.2.4.4. Research Institutes
9.2.4.5. Others
9.3. Asia-Pacific Smart Pill Market Revenue Forecast till 2025
9.3.1. Asia-Pacific Smart Pill Market by Application Type (Option 3: 25% customization)
9.3.1.1. Capsule Endoscopy
9.3.1.2. Drug Delivery
9.3.1.3. Patient Monitoring
9.3.2. Asia-Pacific Smart Pill Market by Target Area
9.3.2.1. Esophagus
9.3.2.2. Stomach
9.3.2.3. Small Intestine
9.3.2.4. Large Intestine
9.3.2.5. Others
9.3.3. Asia-Pacific Smart Pill Market by Indication
9.3.3.1. Esophageal Diseases
9.3.3.2. Small Bowel Diseases
9.3.3.3. Colon Diseases
9.3.3.4. Others
9.3.4. North America Smart Pill Market by End User
9.3.4.1. Hospital
9.3.4.2. Diagnostic laboratories
9.3.4.3. Ambulatory surgical Center
9.3.4.4. Research Institutes
9.3.4.5. Others
9.4. Rest of the World Smart Pill Market Revenue Forecast till 2025
9.4.1. Rest of the World Smart Pill Market by Application Type (Option 4: 25% customization)
9.4.1.1. Capsule Endoscopy
9.4.1.2. Drug Delivery
9.4.1.3. Patient Monitoring
9.4.2. Rest of the World Smart Pill Market by Target Area
9.4.2.1. Esophagus
9.4.2.2. Stomach
9.4.2.3. Small Intestine
9.4.2.4. Large Intestine
9.4.2.5. Others
9.4.3. Rest of the World Smart Pill Market by Indication
9.4.3.1. Esophageal Diseases
9.4.3.2. Small Bowel Diseases
9.4.3.3. Colon Diseases
9.4.3.4. Others
9.4.4. Rest of the World Smart Pill Market by End User
9.4.4.1. Hospital
9.4.4.2. Diagnostic laboratories
9.4.4.3. Ambulatory surgical Center
9.4.4.4. Research Institutes
9.4.4.5. Others
10. Competitive Landscape
10.1. Intensity mapping by key Players
10.2. Porter 5 Analysis
10.3. Major players and their key strategies
10.4. Company Share Analysis
11. Company Profiles (Option 5: 25% Customization – Profiles of 5 Additional Companies of your Choice)
11.1. Boston Scientific Corporation
11.1.1. Company Overview
11.1.2. Financials
11.1.3. Recent Developments
11.2. Capsovision Inc.
11.2.1. Company Overview
11.2.2. Financials
11.2.3. Recent Developments
11.3. Chongqing Jinshan Science & Technology Group Co. Ltd.
11.3.1. Company Overview
11.3.2. Financials
11.3.3. Recent Developments
11.4. Fujifilm Holdings Corporation
11.4.1. Company Overview
11.4.2. Financials
11.4.3. Recent Developments
11.5. GE Healthcare
11.5.1. Company Overview
11.5.2. Financials
11.5.3. Recent Developments
11.6. Olympus Corporation
11.6.1. Company Overview
11.6.2. Financials
11.6.3. Recent Developments
11.7. Pentax Medical Company
11.7.1. Company Overview
11.7.2. Financials
11.7.3. Recent Developments
11.8. Proteus Digital Health Inc.
11.8.1. Company Overview
11.8.2. Financials
11.8.3. Recent Developments
11.9. Proteus Digital Health Inc.
11.9.1. Company Overview
11.9.2. Financials
11.9.3. Recent Developments
11.10. Karl Storz SE & Co. KG
11.10.1. Company Overview
11.10.2. Financials
11.10.3. Recent Developments
12. About GMI Research

Buy Report @ https://tinyurl.com/ya2rr4ba

Related Report :

Global AI for Drug Discovery Market by Drug Type (Small Molecule and Large Molecules), By Technology (Deep Learning and machine learning), By Therapeutic Type (Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases and Others) End-Users (Pharmaceutical Companies, Biopharmaceutical Companies, Academic and Research Institutes and Others) and by Geography – Opportunities & Forecast, 2018-2025

About US

GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition.

GMI Research leverages its industry expertise and experience to identify the industry trends, big opportunities and potential growth areas across industries. Our Syndicated reports provide actionable insights and covers industry trends, market drivers & restraints, macroeconomics factors, market estimates & forecasts, competitive landscape etc. which helps our clients to strengthen its market position by deploying specific strategies and actions that will lead to higher growth.

Our Customized Research (Market Intelligence and Competitive Intelligence) Offerings

Our clients rely on us for the range of our services to give them the intelligence they need to act decisively. GMI Research offers in-depth market and competitive intelligence solutions by leveraging its industry knowledge and experience to provide accurate insights with a complete picture of the market and competition. To know more about our product offering click on the below link:https://www.gmiresearch.com/productservices/marketcompetitiveintelligence.html

Our Company Profile Solution

Company Profiles provide an insight on competitors, customers, and potential suppliers. We at GMI Research understands that the standard or on shelf company profiles provides little help when it comes to business decision making as it doesn’t cover the information required by the clients.

We have developed a range of company profiles solution to meet our client’s specific business requirements irrespective of their role and the industry they operate in. Our company profiles solutions fit into our client’s business requirements because it provides our client’s with a broader choice of profiles: https://www.gmiresearch.com/productservices/companyprofiles.html

Contact – Sarah Nash

Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland

U.S Office +1 860 881 2270
Europe Office +353 1 442 8820

Email: [email protected]